Clinical Efficacy of a 2-Week Treatment Course of Zuranolone for the Treatment of Major Depressive Disorder and Postpartum Depression: Outcomes From the Clinical Development Program

Clinical Efficacy of a 2-Week Treatment Course of Zuranolone for the Treatment of Major Depressive Disorder and Postpartum Depression: Outcomes From the Clinical Development Program

Introduction Antidepressants that offer a rapid onset of action without requiring chronic use are greatly needed in both major depressive disorder (MDD) and postpartum depression (PPD). Zuranolone is an investigational, oral, neuroactive steroid and GABAA receptor positive allosteric modulator in c...

Full description

Bibliographic Details
Main Authors: A. Clayton, A.J. Cutler, K.M. Deligiannidis, R. Lasser, A.J. Sankoh, J. Doherty, M. Kotecha
Format: Article
Language:English
Published: Cambridge University Press 2022-06-01
Series:European Psychiatry
Subjects:
postpartum depression
zuranolone
rapid onset of action
major depressive disorder
Online Access:https://www.cambridge.org/core/product/identifier/S0924933822002826/type/journal_article

Internet

https://www.cambridge.org/core/product/identifier/S0924933822002826/type/journal_article

Similar Items